Interleukin-17, a salivary biomarker for COVID-19 severity
Article
[키워드] acute respiratory syndrome
Admission
adult COVID-19 patient
Biomarker
Blood
C-reactive protein
can be used
cell-mediated response
Comorbidity
coronavirus
COVID-19
COVID-19 disease severity
COVID-19 patient
COVID-19 severity
cytokine
death
demographics
determine
disease severity
ELISA
evaluated
ferritin
identify
IL-17
Infection
interleukin-17
marker
mechanical ventilation
Non-invasive
Patient
reflected
risk
Saliva
salivary
SARS-CoV-2
serum
severe COVID-19
severe COVID-19 patients
severity
with COVID-19
[DOI] 10.1371/journal.pone.0274841 PMC 바로가기
[DOI] 10.1371/journal.pone.0274841 PMC 바로가기